← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2008Last known activity
Mar 24, 2023
Timeline
2000s
- Aug 1, 2004
Mereo BioPharma— Founded
Drugs by trial phase (33 distinct, 43 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- alpha 1-Antitrypsin Deficiency
- Breast Neoplasms
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Emphysema
- Fallopian Tube Neoplasms
- Graft vs Host Disease
- Hypersensitivity
- Hypogonadism
- Liver Neoplasms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Neoplasm Metastasis
- Neoplasms
- Osteogenesis Imperfecta
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Small Cell Lung Carcinoma
Recent trials (47)
- NCT05715216CollaboratorPhase 2Mar 24, 2023
- NCT05312697CollaboratorPhase 2Apr 28, 2022
- NCT05125809CollaboratorPhase 2/Phase 3Dec 31, 2021
- NCT03986086CollaboratorPhase 1/Phase 2Sep 30, 2021
- NCT04761198Lead sponsorPhase 1/Phase 2Mar 23, 2021
- NCT04539795CollaboratorPhase 1/Phase 2Nov 1, 2020
- NCT03679598CollaboratorPhase 2Nov 30, 2018
- NCT03636347Lead sponsorPhase 2Oct 5, 2018
- NCT03498170Study directorPhase 1Mar 19, 2018
- NCT03498170Lead sponsorPhase 1Mar 19, 2018
- NCT03216486Lead sponsorPhase 2Oct 31, 2017
- NCT03295942Lead sponsorPhase 1Sep 12, 2017
- NCT03118570CollaboratorPhase 2Sep 11, 2017
- NCT03118570Study directorPhase 2Sep 11, 2017
- NCT03119428Lead sponsorPhase 1May 2, 2017
Details
- Founded
- Redwood City, CA, US Aug 1, 2004
- Last known activity
- Mar 24, 2023
Notes
--- Pre-folding founded info: 2015-01-01 London GB https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=307970474 ---